News
Hyliion Q2 Earnings Call Highlights
Key Points
- Interested in Hyliion Holdings Corp.? Here are five stocks we like better.
- Revenue and outlook improved: Q2 revenue rose to $4.9 million from $1.5 million a year earlier, driven
Sound Point Meridian Capital Q1 Earnings Call Highlights
Key Points
- Interested in Sound Point Meridian Capital, Inc.? Here are five stocks we like better.
- Net investment income was $5 million, or $0.24 per share, below the $0.60 per-share
Similarweb Q2 Earnings Call Highlights
Key Points
- Interested in Similarweb Ltd.? Here are five stocks we like better.
- Similarweb reported strong Q2 results, with revenue rising 9% year over year to $77.2 million and its first-ever
Riskified Q2 Earnings Call Highlights
Key Points
- Interested in Riskified Ltd.? Here are five stocks we like better.
- Riskified’s second-quarter revenue rose 22% year over year to $98.7 million, driven by new merchants, upsells and
Performance Food Group Q4 Earnings Call Highlights
Key Points
- Interested in Performance Food Group Company? Here are five stocks we like better.
- Performance Food Group reported broad-based fiscal fourth-quarter growth: Net sales rose 6.4%
Madison Square Garden Entertainment Q4 Earnings Call Highlights
Key Points
- Interested in Madison Square Garden Entertainment Corp.? Here are five stocks we like better.
- MSG Entertainment delivered strong fiscal 2026 results: Revenue exceeded $1 billion, up
Kontoor Brands Q2 Earnings Call Highlights
Key Points
- Interested in Kontoor Brands, Inc.? Here are five stocks we like better.
- Kontoor raised its 2026 profitability outlook while maintaining revenue guidance of $2.66 billion to $2.71
GE Vernova’s AI Power Boom Faces a Profit Test
Key Points
- Interested in GE Vernova Inc.? Here are five stocks we like better.
- GE Vernova posted 22% revenue growth and a record $176 billion backlog in the second quarter of 2026, but adjusted
Western Digital & 2 Momentum Stocks That Could Soar in 2026
Investors should focus on stocks with strong momentum to maximize returns this year. One way to uncover stocks with strong upside potential is to adopt Richard Driehaus’s “buy high and sell higher”
Is BMY's Growth Portfolio Strong Enough to Offset Legacy Drug Declines?
Bristol Myers Squibb BMY is navigating a revenue mix shift as growth products portfolio now assumes a larger role in the business, helping mitigate the impact of declining sales from mature products
Is DXCM Stock Worth Buying as Growth Improves but Valuation Stretches?
DexCom, Inc. DXCM is entering the second half of 2026 with healthier margins, broader reimbursement and a larger continuous glucose monitoring opportunity. The investment question is whether that
Defense ETFs to Buy as Pentagon Pushes to Boost Missile Stockpiles
The Pentagon is currently pressing the U.S. defense contractors to accelerate weapon production dramatically. In a recent memo, deputy defense secretary Steve Feinberg gave major contractors just 21
DXCM Stock Up Nearly 35% YTD: Will the Uptrend Continue in the Rest of 2026?
DexCom DXCM stock has rebounded sharply in 2026, gaining 34.8% after falling 14.7% in 2025, as investors increasingly recognize the company’s improving growth profile and expanding continuous
ISRG's US Procedure Growth Slows: Is ACA Headwind a Temporary Concern?
Intuitive Surgical ISRG has faced a moderation in U.S. procedure growth during the first half of 2026, but management’s commentary suggests the slowdown is more likely a temporary demand-timing
DXCM Rallies 52.5% in 3 Months. Can the Stock Keep Climbing From Here?
DexCom, Inc. DXCM shares have climbed 52.5% in the past three months, a sharp re-rating that raises the standard for further gains. The next leg depends less on momentum alone and more on whether
Can DexCom's Raised 2026 Outlook Sustain Stronger Margin Momentum?
DexCom, Inc. DXCM raised its 2026 revenue and margin outlook after a stronger second quarter, shifting more attention toward profitability. The question is whether better gross margin and operating
Can UNH's Lower Medical Costs Sustain the Earnings Recovery?
UnitedHealth Group Incorporated’s UNH second-quarter results show that its earnings performance is improving. The medical care ratio (MCR) fell to 86.7% from 89.4% a year ago, meaning the company
Is DLR Worth Buying as Growth Accelerates but Valuation Stays Rich?
Digital Realty Trust, Inc. DLR is benefiting from faster expected Core funds from operations (FFO) growth, rising revenue visibility and sustained demand from AI, cloud and enterprise customers. The
DLR Jumps 9.9% in the Past Month as Leasing Momentum Accelerates
Digital Realty Trust, Inc. DLR shares have gained 9.9% in the past four weeks, reflecting stronger operating momentum across leasing, renewals and development. The Zacks Consensus Estimate for
SkyWest Jumps 11% in Past Month. Can SKYW Keep the Momentum Going?
SkyWest, Inc. SKYW shares have advanced 11% in the past month, extending a volatile run for the regional airline operator. The move has been backed by higher production and expanding aircraft
PayPal's Venmo: Can Monetization Sustain Its Mid-Teens Growth?
PayPal Holdings, Inc.’s PYPL Venmo is becoming a bigger part of the company’s growth story as it pushes beyond peer-to-peer payments. In the second quarter of 2026, Venmo's total payment volume
Corteva's Higher 2026 Guidance Puts Investor Focus on Growth Drivers
Corteva, Inc. CTVA delivered a mixed second-quarter 2026 performance, with earnings exceeding expectations while revenues fell short of the Zacks Consensus Estimate. The company raised its full-year
Canadian National Sets Record Grain Movement in 2025-26 Crop Year
Canadian National Railway CNI moved more than 33.8 MMT of grain from Western Canada, surpassing the previous record of 32.6 MMT set in the prior crop year. The record grain movement in the 2025-26
Corteva Growth Improves, But Valuation Limits Upside
Corteva, Inc. CTVA is showing improving earnings momentum as technology adoption, productivity actions and a stronger Seed business support growth. However, the stock’s valuation and ongoing Crop



